Cited by 113Advanced biosensing and bioanalysis techniquesRNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry

The DOI matches its Crossref record; 230 of the 233 references it cites were found in a registry or an index.

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers

Open access

Mercier, Marie-Cécile, Dontenwill, Monique, Choulier, Laurence·2017·Cancers

DOI 10.3390/cancers9060069PMC PMC5483888

Open this paper in CoChat — free account

Abstract

Aptamers are nucleic acids referred to as chemical antibodies as they bind to their specific targets with high affinity and selectivity. They are selected via an iterative process known as ‘selective evolution of ligands by exponential enrichment’ (SELEX). Aptamers have been developed against numerous cancer targets and among them, many tumor cell-membrane protein biomarkers. The identification of aptamers targeting cell-surface proteins has mainly been performed by two different strategies: protein- and cell-based SELEX, when the targets used for selection were proteins and cells, respectively. This review aims to update the literature on aptamers targeting tumor cell surface protein biomarkers, highlighting potentials, pitfalls of protein- and cell-based selection processes and applications of such selected molecules. Aptamers as promising agents for diagnosis and therapeutic approaches in oncology are documented, as well as aptamers in clinical development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/cancers9060069

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Scheme of protein- and cell-based SELEX processes. Briefly, the process of SELEX involves first a selection step: the nucleic acid library is incubated with a target (positive selection), which can be preceded or followed by a counter selection phase to remove non-specific nucleic acid molecules. During the partitioning step, bound and unbound fractions are separated. The bound fraction is amplified to obtain an enriched pool for next round of selection. This process is repeated for n rounds until the pool is enriched for sequences that specifically bind the target. These nucleic acid molecules are cloned and sequenced. Individual sequences are aptamers. (a) Protein-based SELEX. The pre-identified purified protein used as target for the protein-based SELEX is colored in red. (b) Cell-based SELEX on a pre-identified tumor cell-surface biomarker colored in red. (c) Cell-based SELEX on a post-identified tumor cell-surface biomarker. The target, identified at the end of the SELEX process, is colored in red. (d) Cell-based SELEX to a tumor cell type. In this case, no particular cell-surface biomarkers are identified and aptamers are specific to the cell’s molecular signature. The whole cell used for positive selection is colored in red.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,285
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,210
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,667
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P. R., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,519
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Şenbabaoğlu, Y., Schultz, N. D., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,401
Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA
Robertson, D. L., & Joyce, G. F. (1990) · Nature · doi:10.1038/344467a0 · Cited by 1,331
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,020

Show all 233 references

Sorted by citations

Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C. J., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 706
Recent Advances in Aptamer Discovery and Applications
Zhang, Y., Lai, B. S., & Juhas, M. (2019) · Molecules · doi:10.3390/molecules24050941 · Cited by 689
Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
Wang, T., Chen, C., Larcher, L. M., Barrero, R. A., & Veedu, R. N. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.001 · Cited by 538
Perspective on the Future Role of Aptamers in Analytical Chemistry
Wu, Y., Belmonte, I., Sykes, K. S., Xiao, Y., & White, R. J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03853 · Cited by 173
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140
Recent developments in cell-SELEX technology for aptamer selection
Kaur, H. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.07.029 · Cited by 128
Advances in the development of fluorescence probes for cell plasma membrane imaging
Liu, C., Gao, X., Yuan, J., & Zhang, R. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116092 · Cited by 122
The research of aptamer biosensor technologies for detection of microorganism
Yi, J., Xiao, W., Li, G., Wu, P., He, Y., Chen, C., He, Y., Ding, P., & Kai, T. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10940-1 · Cited by 111
Electrochemical biosensors based on polymer nanocomposites for detecting breast cancer: Recent progress and future prospects
Mohammadpour-Haratbar, A., Zare, Y., & Rhee, K. Y. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102795 · Cited by 102
Development of a fluorescence aptasensor for rapid and sensitive detection of Listeria monocytogenes in food
Liu, R., Zhang, Y., Ali, S., Haruna, S. A., He, P., Li, H., Ouyang, Q., & Chen, Q. (2020) · Food Control · doi:10.1016/j.foodcont.2020.107808 · Cited by 97
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
Musumeci, D., Platella, C., Riccardi, C., Moccia, F., & Montesarchio, D. (2017) · Cancers · doi:10.3390/cancers9120174 · Cited by 97
Application of aptamers for in vivo molecular imaging and theranostics
Bouvier‐Müller, A., & Ducongè, F. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.004 · Cited by 89
Development of Phosphorothioate DNA and DNA Thioaptamers
Volk, D. E., & Lokesh, G. L.-R. (2017) · Biomedicines · doi:10.3390/biomedicines5030041 · Cited by 87
Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
Silva, E. C. D., Dontenwill, M., Choulier, L., & Lehmann, M. (2019) · Cancers · doi:10.3390/cancers11050692 · Cited by 81
Self-citation
Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer
Lv, T., Li, Z., Xu, L., Zhang, Y., Chen, H., & Gao, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.06.034 · Cited by 74
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Camorani, S., Passariello, M., Agnello, L., Esposito, S., Collina, F., Cantile, M., Bonito, M. D., Ulasov, I. V., Fedele, M., Zannetti, A., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01694-9 · Cited by 72
Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer
Raval, N., Maheshwari, R., Shukla, H., Kalia, K., Torchilin, V. P., & Tekade, R. K. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112186 · Cited by 64
Aptamer-Based Liquid Biopsy
Wu, L., Wang, Y., Zhu, L., Liu, Y., Wang, T., Liu, D., Song, Y., & Yang, C. J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01194 · Cited by 60
Aptamer-Based Point-of-Care Devices: Emerging Technologies and Integration of Computational Methods
Aslan, Y., Atabay, M., Chowdhury, H. K., Göktürk, I., Saylan, Y., & İnci, F. (2023) · Biosensors · doi:10.3390/bios13050569 · Cited by 58
Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
Sani, S., Messé, M., Fuchs, Q., Pierrevelcin, M., Laquerrière, P., Entz‐Werlé, N., Reita, D., Étienne-Selloum, N., Bruban, V., Choulier, L., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000626 · Cited by 56
Self-citation
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
Affinito, A., Quintavalle, C., Esposito, C. L., Roscigno, G., Vilardo, C., Nuzzo, S., Ricci‐Vitiani, L., Luca, G. D., D, R. P. M., Kichkailo, A. S., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.08.015 · Cited by 56
Computational Frontiers in Aptamer-Based Nanomedicine for Precision Therapeutics: A Comprehensive Review
Kumar, S., Mohan, A., Sharma, N. R., Kumar, A., Girdhar, M., Malik, T., & Verma, A. K. (2024) · ACS Omega · doi:10.1021/acsomega.4c02466 · Cited by 56
Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective
Vandghanooni, S., Eskandani, M., Barar, J., & Omidi, Y. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1669-y · Cited by 53
Aptamer-based lateral flow assays
Schüling, T., Institut für Technische Chemie, L. U. H., Eilers, A., Scheper, T. H., & Walter, J. (2018) · AIMS bioengineering · doi:10.3934/bioeng.2018.2.78 · Cited by 51
Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
Gao, T., Mao, Z., Li, W., & Pei, R. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01668c · Cited by 52
Applications of electrochemical biosensor of aptamers-based (APTASENSOR) for the detection of leukemia biomarker
Nur, Y., Gaffar, S., Hartati, Y. W., & Subroto, T. (2021) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2021.100416 · Cited by 50
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications
Camorani, S., Crescenzi, E., Fedele, M., & Cerchia, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.003 · Cited by 49
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
Shigdar, S. L., Agnello, L., Fedele, M., Camorani, S., & Cerchia, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010028 · Cited by 49
RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma
Fechter, P., Silva, E. C. D., Mercier, M.-C., Noulet, F., Étienne-Selloum, N., Guénot, D., Lehmann, M., Vauchelles, R., Martin, S., Lelong-Rebel, I. H., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.006 · Cited by 45
Self-citation
Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
Qriouet, Z., Cherrah, Y., Sefrioui, H., & Qmichou, Z. (2021) · Molecules · doi:10.3390/molecules26041058 · Cited by 45
Aptamers: novelty tools for cancer biology
Pereira, R. L., Nascimento, I. C., Santos, A. P. D. J., Ogusuku, I. E. Y., Lameu, C., Mayer, G., & Ulrich, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25260 · Cited by 45
An overview on the development of different optical sensing platforms for adenosine triphosphate (ATP) recognition
Sivagnanam, S., Mahato, P., & Das, P. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00209h · Cited by 42
Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth
Bai, C., Gao, S., Hu, S., Liu, X., Li, H., Dong, J., Huang, A., Zhu, L., Zhou, P., Li, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.002 · Cited by 42
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
Rahimizadeh, K., Shamaileh, H. A., Fratini, M., Chakravarthy, M., Stephen, M. W., Shigdar, S. L., & Veedu, R. N. (2017) · Molecules · doi:10.3390/molecules22122070 · Cited by 41
Toward the Selection of Cell Targeting Aptamers with Extended Biological Functionalities to Facilitate Endosomal Escape of Cargoes
Tawiah, K. D., Porciani, D., & Burke, D. H. (2017) · Biomedicines · doi:10.3390/biomedicines5030051 · Cited by 40
Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer
Zhang, H., Wang, Z., Xie, L. Y., Zhang, Y., Deng, T., Li, J., Liu, J., Xiong, W., Zhang, L., Zhang, L., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.07.015 · Cited by 39
Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
Zhang, L., Zhai, B.-Z., Wu, Y., & Wang, Y. (2023) · Drug Delivery · doi:10.1080/10717544.2022.2144541 · Cited by 39
The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer
Roy, D., Pascher, A., Juratli, M. A., & Sporn, J. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115601 · Cited by 37
Detection of Breast Cancer Cells Using Acoustics Aptasensor Specific to HER2 Receptors
Poturnayová, A., Dzubinová, Ľ., Buríková, M., Bízik, J., & Hianik, T. (2019) · Biosensors · doi:10.3390/bios9020072 · Cited by 36
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia
Fang, Z., Wang, X., Sun, Y., Fan, R., Liu, Z., Guo, R., & Xie, D. (2019) · Nanoscale · doi:10.1039/c9nr07391d · Cited by 33
Fluorescent aptasensor for detection of four tetracycline veterinary drugs in milk based on catalytic hairpin assembly reaction and displacement of G-quadruplex
Zhou, C., Zou, H., Sun, C., Ren, D., Xiong, W., & Li, Y. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-0981-2 · Cited by 33
Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters
Rosenkranz, A. A., Slastnikova, T. A., Georgiev, G. P., Zalutsky, M. R., & Sobolev, A. S. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.11.005 · Cited by 34
Aptamers in neuro-oncology: An emerging therapeutic modality
Doherty, C. L., Wilbanks, B. A., Khatua, S., & Maher, L. J., III (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad156 · Cited by 33
Emerging Combination of Hydrogel and Electrochemical Biosensors
Huang, L., Zhou, Y., Hu, X., & Yáng, Z. (2024) · Small · doi:10.1002/smll.202409711 · Cited by 33
Rapid identification of specific DNA aptamers precisely targeting CD33 positive leukemia cells through a paired cell-based approach
Yang, C., Wang, Y., Ge, M. H., Fu, Y. J., Hao, R., Islam, K., Huang, P. C., Chen, F., Sun, J., Hong, D. F., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm01393d · Cited by 32
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
Li, Y., Zhao, J., Xue, Z., Tsang, C., Qiao, X., Dong, L., Li, H., Yang, Y., Yu, B., & Gao, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1053984 · Cited by 32
Aptamers in cancer therapy: problems and new breakthroughs
Jin, B., Guo, Z., Chen, Z., Chen, H., Li, S., Deng, Y., Jin, L. J., Liu, Y., Zhang, Y., & He, N. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02579e · Cited by 33
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation
Esposito, C. L., Autiero, I., Sandomenico, A., Li, H., Bassal, M. A., Ibba, M. L., Wang, D., Rinaldi, L., Ummarino, S., Gaggi, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35222-4 · Cited by 30
Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy
Bayani, A., Abosaoda, M. K., Rizaev, J. A., Nazari, M., Jafari, Z., & Samarkhazan, H. S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01724-w · Cited by 29
Electrochemically synthesized polyanine@Cu-BTC MOF as a bifunctional matrix for aptasensing of tetracycline in aquatic products
Zhan, F., Zhao, Y., Dai, X., Zeng, J., & Wang, Q. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.109512 · Cited by 28
The protean world of non-coding RNAs in glioblastoma
Paulmurugan, R., Malhotra, M., & Massoud, T. F. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01798-6 · Cited by 25
Improving Breast Cancer Treatment Specificity Using Aptamers Obtained by 3D Cell-SELEX
Nelissen, F. H. T., Peeters, W. J. M., Roelofs, T. P., Nagelkerke, A., Span, P. N., & Heus, H. A. (2021) · Pharmaceuticals · doi:10.3390/ph14040349 · Cited by 26
Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development
Wang, B., Kobeissy, F. H., Golpich, M., Cai, G., Li, X., Abedi, R., Haskins, W. E., Tan, W., Benner, S. A., & Wang, K. (2024) · Molecules · doi:10.3390/molecules29051124 · Cited by 25
Aptamer-recognized carbohydrates on the cell membrane revealed by super-resolution microscopy
Jing, Y., Cai, M., Xu, H., Zhou, L., Yan, Q., Gao, J., & Wang, H. (2018) · Nanoscale · doi:10.1039/c8nr00089a · Cited by 25
Aptamers for Targeted Delivery: Current Challenges and Future Opportunities
Chandola, C., & Neerathilingam, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84217 · Cited by 25
A beginners guide to SELEX and DNA aptamers
Stephens, C., Goodey, N. M., & Gubler, U. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115890 · Cited by 24
Anticancer nanomedicines harnessing tumor microenvironmental components
Li, Y., Chen, Z., Gu, L., Duan, Z., Pan, D., Xu, Z., Gong, Q., Li, Y., Zhu, H., & Luo, K. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2050211 · Cited by 24
Enhanced molecular dynamic simulation studies unravel long-range effects caused by sequence variations and partner binding in RNA aptamers
Autiero, I., & Vitagliano, L. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102039 · Cited by 22
Internalized Functional DNA Aptamers as Alternative Cancer Therapies
Marshall, M. L., & Wagstaff, K. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01115 · Cited by 21
DNA Functionalized Spider Silk Nanohydrogels for Specific Cell Attachment and Patterning
Heinritz, C., Lamberger, Z., Kocourková, K., Minařík, A., & Humeník, M. (2022) · ACS Nano · doi:10.1021/acsnano.1c11148 · Cited by 20
CRISPR-Mediated Isogenic Cell-SELEX Approach for Generating Highly Specific Aptamers Against Native Membrane Proteins
Rosch, J. C., Neal, E. H., Balikov, D. A., Rahim, M., & Lippmann, E. S. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00651-y · Cited by 20
Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer
Liu, M., Sun, C., Jiang, J., Wan, L., Hu, C., Wen, C., Huang, G., Ruan, Q., Wu, S., Qiao, D., et al. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03564 · Cited by 21
Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg
Dyakin, V. V., Wısnıewskı, T., & Lajtha, Á. (2021) · Symmetry · doi:10.3390/sym13030455 · Cited by 20
Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity
Uemachi, H., Kasahara, Y., Tanaka, K., Okuda, T., Yoneda, Y., & Obika, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060888 · Cited by 18
Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots
Citartan, M., Kaur, H., Presela, R., & Tang, T. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118483 · Cited by 17
Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy
Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16
Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco‐2 cells
Maimaitiyiming, Y., Yang, C., Wang, Y., Hussain, L., & Naranmandura, H. (2019) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1737 · Cited by 16
Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity
Silva, E. C. D., Foppolo, S., Lhermitte, B., Ingremeau, M., Justiniano, H., Klein, L., Chenard, M., Vauchelles, R., Abdallah, B., Lehmann, M., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101980 · Cited by 15
Self-citation
The Research Advances of Aptamers in Hematologic Malignancies
Liao, Y., Xiong, S., Rehman, Z. U., He, X., Peng, H., Liu, J., & Sun, S. (2023) · Cancers · doi:10.3390/cancers15010300 · Cited by 16
Screening of Aptamer for Breast Cancer Biomarker Calreticulin and Its Application to Detection of Serum and Recognition of Breast Cancer Cell
Sun, M., Yang, G. H., Zhao, Y., & Qu, F. (2020) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(20)60020-2 · Cited by 15
Targeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A3
Wang, C., Lin, B., & Chen, C. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1833156 · Cited by 15
Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives
El-khawaga, A. M., Youssef, O. I., El-dydamoni, O. A., Ragab, W. M., & Mohammed, R. A. E. (2026) · European Journal of Medical Research · doi:10.1186/s40001-025-03804-9 · Cited by 14
Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
Dymova, M. A., Kichkailo, A. S., Kuligina, E. V., & Richter, V. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010151 · Cited by 13
Aptamedicine: a new treatment modality in personalized cancer therapy
Vandghanooni, S., Eskandani, M., Barar, J., & Omidi, Y. (2018) · Bioimpacts · doi:10.15171/bi.2019.09 · Cited by 12
SDA and IDA – Two aptamers to inhibit cancer cell adhesion
Hahn, U. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.018 · Cited by 11
Small molecule-linked programmable DNA for washing-free imaging of cell surface biomarkers
Huang, D.-J., Wu, Z., Yu, R., & Jiang, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.07.091 · Cited by 10
Aptasensors: Employing Molecular Probes for Precise Medical Diagnostics and Drug Monitoring
Lafi, Z. M., Gharaibeh, L. F., Nsairat, H., Asha, N., & Alshaer, W. (2023) · Bioanalysis · doi:10.4155/bio-2023-0141 · Cited by 10
Advances in cancer therapeutics with aptamer-functionalized ZIF-8 formulations for site-specific drug delivery
Tasleem, M. W., Rajpoot, S. R., & Zhang, H. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125816 · Cited by 9
Artificial Intelligence-Driven SELEX Design of Aptamer Panels for Urinary Multi-Biomarker Detection in Prostate Cancer: A Systematic and Bibliometric Review
Slalmi, A., Rabbah, N., Battas, I., Debbarh, I., Medromi, H., & Abourriche, A. (2025) · Biomedicines · doi:10.3390/biomedicines13122877 · Cited by 9
Potential use of aptamers for diagnosis and treatment of pancreatic cancer
Gao, G., Liu, C., Jain, S. A., Li, D., Wang, H., Zhao, Y., & Liu, J. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1564924 · Cited by 9
Unlocking Overexpressed Membrane Proteins to Guide Breast Cancer Precision Medicine
Mendonça, J. B., Fernandes, P. V., Fernandes, D. C., Rodrigues, F. R., Waghabi, M. C., & Tilli, T. M. (2024) · Cancers · doi:10.3390/cancers16071402 · Cited by 7
Aptamers: ushering in new hopes in targeted glioblastoma therapy
Chatterjee, D., Bhattacharya, S., Kumari, L., & Datta, A. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2373306 · Cited by 7
FaptaSyme: A Strategy for Converting a Monomer/Oligomer‐Nonselective Aptameric Sensor into an Oligomer‐Selective One
Evangelista, B., Kim, Y., & Kolpashchikov, D. M. (2018) · ChemBioChem · doi:10.1002/cbic.201800017 · Cited by 7
Aptasensors for Cancerous Exosome Detection
Li, J., Xie, S., Qu, F., & Tan, W. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2341-1_1 · Cited by 5
In situ simultaneous profiling of phosphorylation and ubiquitination by single excitation-duplexed luminescence resonance energy transfer
Ma, F., Zhang, L., Wong, B. J. C., & Lei, J. (2018) · Chemical Communications · doi:10.1039/c8cc01494a · Cited by 5
Advancements in Nanostructured Smart Drug Delivery Systems in Cancer Treatment: Targeted Modification Strategies and Clinical Implications
Tripathi, A., Vaishnaw, B., Jaishwal, P., Samal, P. K., Verma, A., & Singh, N. (2025) · Current Materials Science · doi:10.2174/0126661454366845250618053301 · Cited by 2
Aptamers: promising tool for disease diagnosis and treatment
Padma, K. R., & Don, K. R. (2025) · Ceylon Journal of Science · doi:10.4038/cjs.v53i4.8428 · Cited by 2
Challenges of aptamers as targeting ligands for anticancer therapies
Pranay, K., Gupta, M. K., Devi, S., Sharma, N., & Anand, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00011-7 · Cited by 2
The biosensor application in cancer detections: A review
Emrizal, N., Zain, Z. M., & Heah, K. G. (2023) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2023.031.2.05 · Cited by 2
New therapeutic combination to enhance endocytosis of antibodies and nucleic-acid aptamers targeting EGFR in glioblastoma cellsPreprint
Silva, E. C. D., D’Ancona, C., Justiniano, H., Calco, V., Sensoy, D., Villa, P., Vauchelles, R., Lehmann, M., & Choulier, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.617611 · Cited by 2
Self-citation
APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW
Reddy, M. R., Gubbiyappa, K. S., Rasheed, S. H., & Parameshwar, K. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i1.48266 · Cited by 1
Aptamer-modified ratiometric fluorescent sensor based on metal-enhanced fluorescence for visual and portable detection of β-amyloid protein aggregates
Liang, X., Yin, X., Wang, H., Meng, D., Xu, R., Meng, L., & Yang, Y. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.116909 · Cited by 1
Development and Optimization of A New Aptamer-Based Method for P-Selectin (CD62p) Measurement
Çevik, Ö. D. (2021) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2021.25238 · Cited by 1
Aptamer-mediated nano-therapy for pancreatic cancer
Rahimnia, S. M., Dehghani, S., Saeedi, M., Shad, A., & Robati, R. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19142-8.00013-9 · Cited by 1
Nanotechnology for Cancer Research (Diagnosis and Therapy): Recent Progress and Future Prospects
Wanas, W., Khalifa, D. H., Gamal, H., & El-Kot, S. M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_465 · Cited by 1
Recent Updates for Isolation of Aptamers for Various Biothreat Agents Using Different Strategies and Their Role in Detection Applications
Kumar, V., & Sharma, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8836-1_2 · Cited by 1
Development of diagnostic tools for the detection of Streptococcus agalactiae
Swinburne, H. N. (2018)
[Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].
Zhang, Y., Wang, Y., & Liu, J. (2018) · PubMed Central · doi:10.7499/j.issn.1008-8830.2018.05.016
Aptamers that bind filovirus GP : a new frontier for detection and neutralization of Ebola and Marburg virus
Tawiah, K. D. (2020) · doi:10.32469/10355/86511

Authors: Mercier, M.-C., Dontenwill, M., & Choulier, L.
Affiliations: Centre National de la Recherche Scientifique (FR)
Corresponding author: Choulier, Laurence
ORCID: Dontenwill, Monique
Choulier, Laurence
Venue: Cancers
Publisher: MDPI AG
Published: 2017-06-21
Volume: 9
Issue: 6
Pages: 69
ISSN: 2072-6694 (ISSN-L)
DOI: 10.3390/cancers9060069
PMC: PMC5483888
OpenAlex: W2721117256
Cited by: 113
References: 233
Citations by year: 2026: 7 · 2025: 8 · 2024: 8 · 2023: 17 · 2022: 7 · 2021: 11 · 2020: 15 · 2019: 15 · 2018: 20 · 2017: 5
FWCI: 1.41
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Cancers (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
HAL (submittedVersion, other-oa)
Funders: Agence Nationale de la Recherche (ANR-10-SATT-0001)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
Keywords: aptamers, SELEX, cancer diagnosis, cancer therapeutics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks